Anna Montali Selected Research

Anna Montali Research Topics

Disease

5	Familial Combined Hyperlipidemia (Combined Hyperlipidemia, Familial) 10/2015 - 10/2002
4	Hypercholesterolemia 01/2021 - 01/2008
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 01/2003
3	Atherosclerosis 01/2021 - 01/2003
3	Dyslipidemias (Dyslipidemia) 01/2017 - 11/2007
3	Hyperlipidemias (Hyperlipidemia) 01/2016 - 10/2002
2	Coronary Stenosis (Coronary Artery Stenosis) 01/2021 - 04/2008
2	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 10/2020 - 01/2008
2	Insulin Resistance 01/2017 - 07/2013
2	Atherosclerotic Plaque (Atheroma) 01/2010 - 05/2004
1	Genetic Risk Score 01/2021
1	Hypertriglyceridemia 12/2019
1	Pancreatitis 12/2019
1	Tangier Disease 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2017
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 11/2007
1	Lecithin Cholesterol Acyltransferase Deficiency (Lecithin:Cholesterol Acyltransferase Deficiency) 09/2005
1	Rupture 05/2004
1	Stroke (Strokes) 05/2004
1	Myocardial Infarction 05/2004
1	Ischemic Stroke 05/2004

Drug/Important Bio-Agent (IBA)

6	LipidsIBA 01/2021 - 10/2002
3	CholesterolIBA 01/2021 - 01/2008
3	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021 - 11/2007
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2016 - 10/2002
3	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 10/2015 - 10/2002
3	Insulin (Novolin)FDA Link 01/2015 - 11/2007
2	oxidized low density lipoproteinIBA 10/2020 - 01/2017
2	Triglycerides (Triacylglycerol)IBA 12/2019 - 11/2007
2	Lipoproteins (Lipoprotein)IBA 01/2019 - 01/2016
2	HDL CholesterolIBA 01/2019 - 11/2007
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 11/2007
2	LDL CholesterolIBA 01/2017 - 11/2007
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2010 - 05/2004
2	DNA (Deoxyribonucleic Acid)IBA 01/2008 - 09/2005
2	Fenofibrate (CiL)FDA LinkGeneric 11/2007 - 03/2007
2	Atorvastatin (Lipitor)FDA Link 11/2007 - 03/2007
1	CalciumIBA 01/2021
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2019
1	Apoprotein(a) (Apolipoprotein (a))IBA 01/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2017
1	Transaminases (Aminotransferases)IBA 01/2017
1	Apolipoprotein B-48IBA 01/2016
1	LDL Receptors (LDL Receptor)IBA 10/2015
1	Glucose (Dextrose)FDA LinkGeneric 07/2013
1	Nonesterified Fatty Acids (NEFA)IBA 07/2013
1	Lipase (Acid Lipase)FDA Link 11/2010
1	SterolsIBA 02/2010
1	EnzymesIBA 01/2010
1	NADPH Oxidases (NAD(P)H oxidase)IBA 04/2008
1	omega-Chloroacetophenone (Mace)IBA 04/2008
1	HDL LipoproteinsIBA 11/2007
1	Fibric Acids (Fibrates)IBA 11/2007
1	Pharmaceutical PreparationsIBA 11/2007
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2007
1	OxysterolsIBA 03/2007
1	Metalloproteases (Metalloproteinases)IBA 05/2004
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 05/2004
1	Matrix Metalloproteinases (MMPs)IBA 05/2004
1	Interleukin-1 (Interleukin 1)IBA 01/2003
1	CytokinesIBA 01/2003
1	InterleukinsIBA 01/2003
1	Insulin Receptor Substrate ProteinsIBA 10/2002

Therapy/Procedure

2	Therapeutics 01/2021 - 03/2007